Tirzepatide is a medication primarily used to manage type 2 diabetes, but its also gaining traction as a weight loss solution
doi: 10.3389/fphar.2023.1196287 Received 29 March 2023 Accepted 02 May 2023 Published 15 May 2023 Volume 14 - 2023 Edited by Daniela Gabbia, University of Padova, Italy Reviewed by Xiao Li, Shandong Provincial Qianfoshan Hospital, China Hartmut Kuhn, Charit University Medicine Berlin, Germany Updates Copyright 2023 Lu, Hu, Chen, Li, Yuan, Tian, Cao and Qiu
It is not known if these medicines will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
A patient who has reached and stabilized at their weight loss target may step down to a less-aggressive maintenance therapy